RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hyloris Pharmaceuticals Stock

Hyloris Pharmaceuticals Debt 2024

Hyloris Pharmaceuticals Debt

-28.45 EUR

Ticker

HYL.BR

ISIN

BE0974363955

WKN

A2P7Y0

In 2024, Hyloris Pharmaceuticals's total debt was -28.45 EUR, a -33.18% change from the -42.57 EUR total debt recorded in the previous year.

Hyloris Pharmaceuticals Aktienanalyse

What does Hyloris Pharmaceuticals do?

Hyloris Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Hyloris Pharmaceuticals's Debt Structure

Hyloris Pharmaceuticals's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Hyloris Pharmaceuticals's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Hyloris Pharmaceuticals’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Hyloris Pharmaceuticals’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Hyloris Pharmaceuticals stock

What is the debt of Hyloris Pharmaceuticals this year?

Hyloris Pharmaceuticals has a debt level of -28.45 EUR this year.

What was the debt of Hyloris Pharmaceuticals compared to the previous year?

The debt of Hyloris Pharmaceuticals has increased by -33.18% compared to the previous year dropped.

What are the consequences of high debt for investors in Hyloris Pharmaceuticals?

High debt can pose a risk for investors of Hyloris Pharmaceuticals, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Hyloris Pharmaceuticals?

Low debt means that Hyloris Pharmaceuticals has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Hyloris Pharmaceuticals affect the company?

An increase in debt of Hyloris Pharmaceuticals can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Hyloris Pharmaceuticals affect the company?

A reduction in debt of Hyloris Pharmaceuticals can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Hyloris Pharmaceuticals?

Some factors that can influence the debt of Hyloris Pharmaceuticals include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Hyloris Pharmaceuticals so important for investors?

The debts of Hyloris Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Hyloris Pharmaceuticals take to change the debt?

To change the debt, Hyloris Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Hyloris Pharmaceuticals pay?

Over the past 12 months, Hyloris Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hyloris Pharmaceuticals is expected to pay a dividend of 0 EUR.

What is the dividend yield of Hyloris Pharmaceuticals?

The current dividend yield of Hyloris Pharmaceuticals is .

When does Hyloris Pharmaceuticals pay dividends?

Hyloris Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hyloris Pharmaceuticals?

Hyloris Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Hyloris Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Hyloris Pharmaceuticals located?

Hyloris Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hyloris Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hyloris Pharmaceuticals from 11/5/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/5/2024.

When did Hyloris Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/5/2024.

What was the dividend of Hyloris Pharmaceuticals in the year 2023?

In the year 2023, Hyloris Pharmaceuticals distributed 0 EUR as dividends.

In which currency does Hyloris Pharmaceuticals pay out the dividend?

The dividends of Hyloris Pharmaceuticals are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hyloris Pharmaceuticals

Our stock analysis for Hyloris Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hyloris Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.